Tandem Diabetes and Eli Lilly Collaborate on Insulin Pump Tech
Tandem Diabetes Care Partners with Eli Lilly for New Technology
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), known for its innovation in insulin delivery systems, recently announced an exciting development. Their t:slim X2 insulin pump is now approved for use with Eli Lilly and Company’s Lyumjev ultra-rapid acting insulin in the United States. This marks a significant advancement in the tools available for managing diabetes.
Enhancing Diabetes Management with Smart Technology
Jordan Pinsker, MD, Chief Medical Officer at Tandem, highlighted this progression, stating, "This latest milestone reinforces our commitment to facilitating choice and access for people who rely on insulin therapy." This enhancement allows individuals aged two and above with type 1 diabetes, as well as adults with type 2 diabetes, to use Lyumjev in conjunction with the t:slim X2 pump. The flexibility offered here is a vital improvement for those managing diabetes.
Groundbreaking Study Results Support the Clearance
The approval for use of Lyumjev with the t:slim X2 was based on compelling data obtained from a 13-week multicenter study involving 179 participants. This research demonstrated high satisfaction levels and notable quality of life improvements among users. Although Lyumjev received general approval for use in insulin pumps in 2021, individual pump manufacturers had to validate compatibility through thorough testing.
Collaboration Between Tandem and Eli Lilly
Tandem and Lilly have diligently worked together to support this clinical trial, which corroborated the benefits of utilizing Lyumjev alongside Control-IQ+ technology. Furthermore, the companies are focused on securing compatibility for the Tandem Mobi pump with Lyumjev, further expanding options for patients.
Access and Support Through Lilly’s Insulin Value Program
Lyumjev is accessible to a large number of patients through the Lilly Insulin Value Program, which allows individuals with commercial insurance, as well as those without coverage, to fill a monthly prescription for just $35. This affordability initiative exemplifies a commitment to making necessary treatments accessible.
Broader Applicability of the t:slim X2 Pump
The t:slim X2 insulin pump has also been approved for use with other insulin types, including Humalog and Novolog, broadening the spectrum of choices available to users. This approval significantly enhances the versatility of the pump and its ability to cater to various patient needs.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care is committed to revolutionizing the management of diabetes through its cutting-edge insulin delivery systems. Their offerings include advanced technologies, such as the Tandem Mobi system and the t:slim X2 insulin pump, both of which incorporate the state-of-the-art Control-IQ+ technology. Based out of San Diego, the company focuses on reducing the strain of diabetes management for patients, healthcare providers, and families.
Connect With Tandem Diabetes Care
To stay updated about Tandem Diabetes Care, you can follow them on TikTok, and their various social media platforms, including Facebook, Instagram, LinkedIn, and X.
Frequently Asked Questions
What is the significance of the t:slim X2 insulin pump?
The t:slim X2 insulin pump is significant because it offers advanced features that help individuals manage their diabetes more effectively, including compatibility with innovative insulins like Lyumjev.
How does Control-IQ+ technology benefit users?
Control-IQ+ technology automatically adjusts insulin delivery based on glucose readings, helping to stabilize blood sugar levels and reduce the burden of diabetes management.
Who can use the t:slim X2 pump with Lyumjev?
Individuals aged two and older with type 1 diabetes, as well as adults with type 2 diabetes, can use the t:slim X2 pump with Lyumjev for insulin delivery.
How does the Lilly Insulin Value Program work?
The Lilly Insulin Value Program allows eligible individuals with or without insurance to obtain a monthly prescription of Lyumjev for only $35, making it more accessible.
What other insulins are compatible with the t:slim X2 pump?
In addition to Lyumjev, the t:slim X2 insulin pump is also approved for use with Humalog and Novolog insulin types, offering users more treatment options.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.